Leiden researchers, led by Sebastian Pomplun, have developed a new method to screen hundreds of thousands of molecules for ...
The Chosun Ilbo on MSN
Cosmax Unveils Vegan PDRN Through Biosynthesis
Global cosmetics ODM (research, development, and production) company Cosmax recently succeeded in diversifying the synthesis ...
In the 24 years since 9/11, Diane Keating has never given an interview. Why now? “People and families need to know they are still looking,” she told Spectrum News. Nearly a quarter of a century on, ...
From October 28th to 30th, Kexing Biopharm participated in CPHI Frankfurt 2025, one of the world's most influential pharmaceutical exhibitions, presenting its key product portfolio and international ...
RESEARCHERS at Massachusetts Institute of Technology (MIT) have developed a method to purify gene therapies 10 times more quickly than conventional processes, paving the way to lower prices for the ...
This important study presents a thoughtful design and characterization of chimeric influenza hemagglutinin (HA) head domains combining elements of distinct receptor-binding sites. The results provide ...
Chile is home to one of the world’s largest salmon-farming industries, making it a vital hub for aquaculture vaccine demand. Salmon alone accounts for about 85 % of the vaccines used in Chile’s ...
Chemists at the National University of Singapore (NUS) have found a new use for deoxyribonucleic acid (DNA), not just as ...
ETH Zurich scientists have created “MetaGraph,” a revolutionary DNA search engine that functions like Google for genetic data. By compressing global genomic datasets by a factor of 300, it allows ...
Live Science on MSNOpinion
One molecule could usher revolutionary medicines for cancer, diabetes and genetic disease — but the US is turning its back on it
The U.S. government is divesting from mRNA vaccines, but will other uses of the technology be spared? In a time of ...
6don MSN
Clinical trial presents promising DNA-encoded therapy for long-lasting protection against COVID-19
A new way to deliver protective antibodies against COVID-19 was tested in a Phase I clinical trial. Instead of injecting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results